CTRI/2016/09/007299尚未招募未知
A study on twice daily split dosage of deferasirox and its effect on serum ferritin level in beta-thalassemia patients-a hospital based quasi-experimental study - TDTD
issar moopan0 个研究点目标入组 25 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 25
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •All patients diagnosed with beta thalassemia and on regular blood transfusion receiving once daily deferasirox.
- •2)Serum ferritin > 1500 mcg/L.
- •3)All thalassemia patients who are not on regular IV chelation therapy (receiving IV chelation during every transfusion)
排除标准
- •1)All thalasemia patients who are on oral deferiprone therapy.
研究者
相似试验
已完成
2 期
Effect of Osveral on iron overload in beta thalassemia major patients.beta thalassemia.beta thalassemiaIRCT2015102524679N2Investigator69
招募中
不适用
Efficay comparison two oral chelators combination in patients with beta-thalassemiaIRCT20160310026998N7Tabriz University of Medical Sciences54
进行中（未招募）
不适用
Phase I study to examine the effect of deferasirox on renal hemodynamics in β-thalassemia patients with transfusional iron overload - NDMedDRA version: 6.1Level: HLGTClassification code 10022958thalassemiaEUCTR2006-006838-17-ITOVARTIS FARMA8
尚未招募
4 期
Bioequivalence Study of 500 mg Deferasirox Dispersible Tablets in Healthy Thai under Fasting ConditioBioequivalence studyTCTR20170222005Research and Development36
已完成
3 期
Compare the efficacy of combination therapy of Deferasirox and Deferiprone in reducing iron load in patients with transfusion-Dependent ß-Thalassemia.transfusion-Dependent ß-Thalassemia.Beta thalassemiaIRCT20190106042262N1Esfahan University of Medical Sciences108